SCHEMBL28048494

SCHEMBL28048494

CC(=O)Nc1cccc2c1CCC2Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.51
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
SLC18A3 Q16572 1/20 0.39
MAOA P21397 1/20 0.38
DRD2 P14416 3/20 0.38
DRD1 P21728 3/20 0.38
POLB P06746 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 2/20 0.37
PARP14 Q460N5 1/20 0.37
GAA P10253 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
FFAR2 O15552 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1356196 0.83 ADRA2A (0.52) ADRA2ANPC1RAB9AALDH1A1HPGD
SCHEMBL28048491 0.82 ADRA2A (0.51) ADRA2ANPC1RAB9AALDH1A1HPGD
SCHEMBL7215968 0.75 ADRA2A (0.46) ADRA2ANPC1RAB9AALDH1A1HPGD
Hydrochloric Acid SCHEMBL7324843 0.74 ADRA2A (0.45) ADRA2ANPC1RAB9AALDH1A1HPGD
SCHEMBL1010394 0.74 ADRA2A (0.49) ADRA2ANPC1RAB9AALDH1A1HPGD
Hydrochloric Acid SCHEMBL9593660 0.73 ADRA2A (0.44) ADRA2ANPC1RAB9AALDH1A1HPGD
SCHEMBL11629630 0.73 DRD2 (0.56) ALDH1A1HPGDDDB1CRBNDRD2
SCHEMBL8012751 0.72 ADRA2A (0.46) ADRA2ANPC1RAB9AALDH1A1HPGD
SCHEMBL7215973 0.72 ADRA2A (0.43) ADRA2ANPC1RAB9AALDH1A1CRBN
SCHEMBL11635433 0.71 DRD2 (0.44) ADRA2AALDH1A1HPGDDRD2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103619814-B Amino-pyrroline derivatives and their use in the prevention and/or treatment of metabolic syndrome UNIVERSITE DE STRASBOURG (FR) 2016-01-20 CN disclosed